Brought to you by 
Addex Pharmaceuticals completes Euro10mm first round
29 Aug 2002
Executive Summary
Addex Pharmaceuticals SA, a biopharmaceutical company developing compounds for the treatment of addiction and other neuropsychiatric conditions, raised Euro10mm ($9.9mm) in a first round private placement. The financing was co-led by Index Ventures and Sofinnova Partners, and included Techno Venture Management, BCV Initiative Capital, and individual investors.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Addex Pharmaceuticals completes Euro10mm first round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice